news-med.jpg

Evotec partner Haplogen enters into collaboration with Bayer

Focus on pulmonary diseases with high unmet medical need Integrated Haplogen-Bayer collaboration builds upon pulmonary portfolio created by Evotec and Haplogen Evotec will participate in undisclosed upfront as well as potential milestone and royalty-based payments from Bayer to Haplogen

Topics: Corporate, Bayer, Evotec, pulmonary diseases, Haplogen Read More